Tremor: Clinical Trials

150 trials for Tremor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

79 completed, 32 recruiting, 25 unknown, 3 active not recruiting. 53 Not applicable, 25 Phase 2, 11 Phase 3, 10 Phase 1, 10 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable53Completed 30, Recruiting 9, Unknown 7, Active not recruiting 2, Enrolling by invitation 2, Not yet recruiting 2, Withdrawn 1
Phase 225Completed 14, Recruiting 5, Unknown 3, Withdrawn 2, Not yet recruiting 1
Phase 311Completed 7, Recruiting 2, Terminated 1, Unknown 1
Phase 110Completed 5, Recruiting 3, Not yet recruiting 1, Unknown 1
Phase 410Completed 5, Recruiting 3, Terminated 1, Unknown 1
Early Phase 14Recruiting 2, Completed 1, Unknown 1

Follow Tremor: new trials by email Literature Review of Tremor trials Research Report on Tremor

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus)
Glycerol Tributyrate - MELAS Syndrome, Lebers Hereditory Optic Neuropathy With Extra Ocular Symptoms (LHON-Plus)
Phase 1 / Phase 2Not yet recruitingGeorge Washington University242027-03-012026-10-05
Wearable for Assessing Tremor and Continuous Health in Parkinson's Disease and Essential Tremor
Device exposure: Wearable inertial sensor monitoring - PARKINSON DISEASE (Disorder)
RecruitingHeriot-Watt University602026-11-012026-10-09
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
VIM0423, VIM0423 Placebo - PARKINSON DISEASE (Disorder)
Phase 2RecruitingVima Therapeutics802026-09-152026-11-10
Comparison of Benzhexol and Procyclidine for Tremor in Tremor-Predominant Parkinson's Disease
Benzhexol, Procyclidine - Parkinson Disease (PD)
Not applicableRecruitingsafia bano882026-09-012026-09-14
Effects of Targeted Temporal Interference Stimulation of Cerebellar Nuclei on Tremor and Gait Disturbance in Parkinson's Disease Patients
Sham Temporal Interference Stimulation, Real Temporal Interference Stimulation - Parkinson's Disease, Movement Disorders
Not applicableNot yet recruitingYangPan502026-08-192026-06-10
Effects of Transcutaneous Vagus Nerve Stimulation in Parkinson´s Disease
Transcutaneous Electrical Nerve Stimulation (TENS) of Vagus Nerve, Conventional Physical therapy, Conventional Speech Therapy - Transcutaneous Vagal Nerve Stimulation (tVNS), Parkinson Disease (PD)
Not applicableActive not recruitingUniversidade da Coruña462026-05-252026-08-07
Open Label Study for the Use of Low Intensity Focused Ultrasound for Essential Tremor
Low Intensity Focused Ultrasound (LIFU) - Essential Tremor
Early Phase 1RecruitingUniversity of California, Los Angeles202026-05-012026-05-20
Neurocognitive Function Changes With Extended-Release Tacrolimus Among Older Kidney Transplant Recipients
Conversion to extended-release tacrolimus, Maintenance of immediate-release tacrolimus - Kidney Transplant Recipients, Old Age
Phase 4RecruitingMassachusetts General Hospital922026-03-172026-05-28
Connectomic Guided DBS for Parkinson's Disease
Cerebellothalamic optimized deep brain stimulation, Pallidothalamic optimized deep brain stimulation, No deep brain stimulation - Parkinson Disease, Tremor
Not applicableEnrolling by invitationDuke University202026-02-162026-09-03
Detection of Internal Tremors by Oscillometry in Parkinson's Patient
Detection of objective internal tremors - Parkinson Disease
Not applicableRecruitingUniversity Hospital, Toulouse602026-02-102026-02-17
Deep Brain Stimulation of the Deep Cerebellar Nuclei for Refractory Tremor
Deep Brain Stimulation - Tremor, Essential Tremor
Phase 1RecruitingThe Cleveland Clinic122026-01-152026-07-10
Virtual tES Device Treatment for Parkinson's Disease Motor Symptoms
Transcranial Electrical Stimulation Device - PARKINSON DISEASE (Disorder)
Phase 1 / Phase 2RecruitingU: The Mind Company302026-01-012026-01-27
Effects of Transcutaneous Vagus Nerve Stimulation in Older Adults
Active location tVNS, Sham Comparator - Older Adults Without Any Specific Clinical Condition, Autonomic Nervous System Imbalance
Not applicableCompletedUniversidade da Coruña122025-12-192026-03-02
First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)
ALN-SNCA, Placebo - Parkinsons Disease
Phase 1RecruitingRegeneron Pharmaceuticals462025-12-052026-09-21
MRgFUS for Parkinson's Tremor
MR-guided focused ultrasound thalamotomy - Parkinson s Disease, Tremor
Not applicableRecruitingAarhus University Hospital202025-12-012026-01-07
Gluten Challenge in Celiac Disease - Which Formulation of Gluten Gives the Best Response?
Vital wheat gluten - Celiac Disease
Not applicableRecruitingOslo University Hospital302025-08-012026-04-17
Modulate Tremor Severity With Low-intensity Focused Ultrasound Stimulation Targeting the Deep Nucleus of Patients With Refractory Hand Tremor.
Accelerated NaviFUS-ctbFUS stimulation - Parkinson Disease (PD), Essential Tremor
Not applicableRecruitingNational Taiwan University Hospital122025-06-112025-09-15
Cerebellar Transcranial Alternating Current Stimulation (tACS) to Modulate Parkinson's Disease Tremor
Active-tACS, Sham-tACS, Unlocked-tACS - Parkinson's Disease (PD), Tremor
Not applicableRecruitingUniversitätsklinikum Hamburg-Eppendorf102025-04-162026-09-01
The Efficacy of Aldehyde Dehydrogenase Enzyme in Essential Tremor Patients: A Single-Center Study
PICOZYME ET - Essential Tremor
Not applicableCompletedPico Entech Co., Ltd.312025-03-102026-09-29
Effect of Kinesiotaping on Tremor in People With Parkinson's Disease
Therapeutic Kinesiotaping, Sham Taping, Home Exercise Program - PARKINSON DISEASE (Disorder), Tremor
Not applicableCompletedSultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey452025-03-012026-04-29

Showing 20 of 150. Sign in to see all of them.

Narrower conditions

Parkinson Disease (74)  ·  Essential Tremor (45)  ·  Movement Disorders (20)  ·  Dyskinesias (14)  ·  Dystonia (14)  ·  Hypokinesia (10)  ·  Dysphonia (6)  ·  Nervous System Diseases (6)  ·  Multiple Sclerosis (5)  ·  Muscle Rigidity (5)  ·  Parkinsonian Disorders (5)  ·  Anxiety Disorders (4)  ·  Central Nervous System Diseases (4)  ·  Dystonic Disorders (4)

Broader conditions

Pathological Conditions, Signs and Symptoms (150)  ·  Signs and Symptoms (150)  ·  Neurologic Manifestations (147)  ·  Nervous System Diseases (144)  ·  Dyskinesias (136)  ·  Central Nervous System Diseases (108)  ·  Movement Disorders (90)  ·  Brain Diseases (78)  ·  Basal Ganglia Diseases (76)  ·  Synucleinopathies (75)  ·  Neurodegenerative Diseases (74)  ·  Parkinsonian Disorders (71)  ·  Mental Disorders (19)  ·  Otorhinolaryngologic Diseases (10)  ·  Musculoskeletal Diseases (9)

Interventions

Deep Brain Stimulation (7)  ·  Botulinum Toxins, Type A (4)  ·  Tacrolimus (4)  ·  Ethanol (3)  ·  Radiosurgery (3)  ·  incobotulinumtoxinA (3)  ·  1-Octanol (2)  ·  Cannabidiol (2)  ·  Propranolol (2)  ·  Saline Solution (2)  ·  octanoic acid (2)  ·  Alprazolam (1)  ·  Amantadine (1)  ·  Bupivacaine (1)  ·  Clonidine (1)

Sponsors

National Institute of Neurological Disorders and Stroke (NINDS) (10)  ·  Great Lakes NeuroTechnologies Inc. (8)  ·  University of Florida (4)  ·  Abbott Medical Devices (3)  ·  InSightec (3)  ·  Jazz Pharmaceuticals (3)  ·  Massachusetts Eye and Ear Infirmary (3)  ·  Rambam Health Care Campus (3)  ·  University of British Columbia (3)  ·  Duke University (2)  ·  Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta (2)  ·  KU Leuven (2)  ·  Maria Sklodowska-Curie National Research Institute of Oncology (2)  ·  Medical University of Graz (2)  ·  Oslo University Hospital (2)

Countries

United States (77)  ·  Canada (13)  ·  Spain (10)  ·  France (8)  ·  Germany (6)  ·  Israel (6)  ·  Italy (5)  ·  Taiwan (5)  ·  United Kingdom (5)  ·  Australia (4)  ·  Netherlands (4)  ·  Poland (4)  ·  Turkey (Türkiye) (4)  ·  South Korea (3)  ·  Austria (2)

Top investigators

Dustin A Heldman, PhD (4)  ·  Kristina Simonyan, MD, PhD (4)  ·  Kenneth Follett (2)  ·  Adityanjee Adityanjee, MD (1)  ·  Agessandro Abrahao, MD, MSc (1)  ·  Alan Glicklich, MD (1)  ·  Aleksandra Napieralska (1)  ·  Ali Veysel Ozden, M.D. (1)  ·  Amy W Amara, MD, phD (1)  ·  Andrew Evans, MD (1)  ·  Anne Bernassau (1)

Results publications

PMID 19126811, PMID 20519680, PMID 23667214, PMID 25185211, PMID 41626017, PMID 10665942, PMID 11391740, PMID 11812709, PMID 12768180, PMID 14718713, PMID 15210907, PMID 15233821, PMID 16216957, PMID 16381181, PMID 17052655, PMID 17845632, PMID 18433676, PMID 19218475, PMID 19454631, PMID 19940187, PMID 20175185, PMID 20201005, PMID 20830819, PMID 20937936, PMID 21384292, PMID 21594724, PMID 22454323, PMID 22722632, PMID 23408867, PMID 25929664, PMID 26621764, PMID 26927672, PMID 27101283, PMID 27622717, PMID 27720703, PMID 27808415, PMID 28789780, PMID 28991711, PMID 29193359, PMID 29204312, PMID 29742376, PMID 29777361, PMID 30382161, PMID 30945105, PMID 31111094, PMID 32815611, PMID 32873195, PMID 33096872, PMID 33510610, PMID 34454047

NIH funding

2016 (1), 2025 (1), 5UH3NS095553-04 (1), K23NS044997 (1), R01DC012545 (1), R01NS058487 (1), R01NS073683 (1), R03DC012429 (1), R37NS040894 (1), R43NS081902 (1), R44AG033947 (1), R44AG044293 (1), R44MD004049 (1), UH3TR003897 (1)